Safety of high-dose ivermectin: a systematic review and meta-analysis

Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2–12 years

(2019) Jessica D Schulz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Collateral Benefits of Preventive Chemotherapy — Expanding the War on Neglected Tropical Diseases

(2019) Peter J. Hotez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serious Neurological Adverse Events after Ivermectin—Do They Occur beyond the Indication of Onchocerciasis?

(2018) Rebecca E. Chandler   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Efficacy and Safety of Ivermectin Against Trichuris trichiura in Preschool-aged and School-aged Children: A Randomized Controlled Dose-finding Trial

(2018) David Wimmersberger et al.   CLINICAL INFECTIOUS DISEASES

Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial

(2018) Menno R Smit et al.   LANCET INFECTIOUS DISEASES

Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature

(2018) Philip J. Budge et al.   PLoS Neglected Tropical Diseases

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers

(2018) Jose Muñoz et al.   PLoS Neglected Tropical Diseases

Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-prolongation (IVERMAL)

(2018) Menno R. Smit et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria

(2017) Frank O. Richards   MALARIA JOURNAL

Ivermectin to reduce malaria transmission III. Considerations regarding regulatory and policy pathways

(2017) Carlos Chaccour et al.   MALARIA JOURNAL

Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study

(2017) Adriana Echazú et al.   PLoS Neglected Tropical Diseases

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

(2017) Peter U. Fischer et al.   PLoS Neglected Tropical Diseases

Mass Drug Administration for Scabies Control in a Population with Endemic Disease

(2015) Lucia Romani et al.   NEW ENGLAND JOURNAL OF MEDICINE

The advent of ivermectin: people, partnerships, and principles

(2014) Andy Crump   TRENDS IN PARASITOLOGY

Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination

(2013) Carlos J Chaccour et al.   MALARIA JOURNAL

Ivermectin, ‘Wonder drug’ from Japan: the human use perspective

(2011) Andy CRUMP et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Preventive chemotherapy in human helminthiasis: theoretical and operational aspects

(2011) A.-F. Gabrielli et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Use of High‐Dose, Twice‐Yearly Albendazole and Ivermectin to SuppressWuchereria bancroftiMicrofilarial Levels

(2010) Benoit Dembele et al.   CLINICAL INFECTIOUS DISEASES

Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis

(2010) B. Thylefors et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Mass Drug Administration and Integrated Control for the World's High-Prevalence Neglected Tropical Diseases

(2009) PJ Hotez   CLINICAL PHARMACOLOGY & THERAPEUTICS

Unresolved issues in anthelmintic pharmacology for helminthiases of humans

(2009) Timothy G. Geary et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY